Prevalence of high-risk human papillomavirus and its genotype distribution in head and neck squamous cell carcinomas
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: High-risk (HR) human papillomavirus (HPV) is found in a subset of head and neck (HN) squamous cell carcinomas (SCCs). For oropharyngeal SCCs, HR HPV positivity is known to be associated with good prognosis, and a separate staging system for HPV-associated carcinomas using p16 immunohistochemistry (IHC) as a surrogate test has been adopted in the 8th American Joint Committee on Cancer staging system. We examined the HR HPV status and the genotype distribution in five HN subsites. Methods: Formalin-fixed paraffin-embedded tissue sections were used for p16 IHC and DNA extraction. HPV DNA detection and genotyping were done employing either a DNA chip-based or real-time polymerase chain reaction–based method. Results: During 2011–2019, a total of 466 SCCs were tested for HPV DNA with 34.1% positivity for HR HPV. Among HN subsites, the oropharynx showed the highest HR HPV prevalence (149/205, 75.1%), followed by the sinonasal tract (3/14, 21.4%), larynx (5/43, 11.6%), hypopharynx (1/38, 2.6%), and oral cavity (1/166, 0.6%). The most common HPV genotype was HPV16 (84.3%) followed by HPV35 (6.9%) and HPV33 (4.4%). Compared with HR HPV status, the sensitivity and specificity of p16 IHC were 98.6% and 94.3% for the oropharynx, and 99.2% and 93.8% for the tonsil, respectively. Conclusions: Using a Korean dataset, we confirmed that HR HPV is most frequently detected in oropharyngeal SCCs. p16 positivity showed a good concordance with HR HPV DNA for oropharyngeal and especially tonsillar carcinomas. The use of p16 IHC may further be extended to predict HR HPV positivity in sinonasal tract SCCs.
Abstract
Background: High-risk (HR) human papillomavirus (HPV) is found in a subset of head and neck (HN) squamous cell carcinomas (SCCs). For oropharyngeal SCCs, HR HPV positivity is known to be associated with good prognosis, and a separate staging system for HPV-associated carcinomas using p16 immunohistochemistry (IHC) as a surrogate test has been adopted in the 8th American Joint Committee on Cancer staging system. We examined the HR HPV status and the genotype distribution in five HN subsites. Methods: Formalin-fixed paraffin-embedded tissue sections were used for p16 IHC and DNA extraction. HPV DNA detection and genotyping were done employing either a DNA chip-based or real-time polymerase chain reaction–based method. Results: During 2011–2019, a total of 466 SCCs were tested for HPV DNA with 34.1% positivity for HR HPV. Among HN subsites, the oropharynx showed the highest HR HPV prevalence (149/205, 75.1%), followed by the sinonasal tract (3/14, 21.4%), larynx (5/43, 11.6%), hypopharynx (1/38, 2.6%), and oral cavity (1/166, 0.6%). The most common HPV genotype was HPV16 (84.3%) followed by HPV35 (6.9%) and HPV33 (4.4%). Compared with HR HPV status, the sensitivity and specificity of p16 IHC were 98.6% and 94.3% for the oropharynx, and 99.2% and 93.8% for the tonsil, respectively. Conclusions: Using a Korean dataset, we confirmed that HR HPV is most frequently detected in oropharyngeal SCCs. p16 positivity showed a good concordance with HR HPV DNA for oropharyngeal and especially tonsillar carcinomas. The use of p16 IHC may further be extended to predict HR HPV positivity in sinonasal tract SCCs.
참고문헌 (46)
- de Sanjose S, "Human papillomavirus genotype attribution in invasive cervical cancer : a retrospective cross-sectional worldwide study", Lancet Oncol, 11, pp.1048~1056 (2010)
- de Martel C, "Worldwide burden of cancer attributable to HPV by site, country and HPV type", Int J Cancer, 141, pp.664~670 (2017)
- Gillison ML, "Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma", J Clin Oncol, 33, pp.3235~3242 (2015)
- Moody CA, "Human papillomavirus oncoproteins : pathways to transformation", Nat Rev Cancer, 10, pp.550~560 (2010)
- Lewis JS Jr, "p16 immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma", Head Neck Pathol, 6(Suppl 1), pp.S75~S82 (2012)
- Rischin D, "Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial", J Clin Oncol, 28, pp.4142~4148 (2010)
- Ang KK, "Human papillomavirus and survival of patients with oropharyngeal cancer", N Engl J Med, 363, pp.24~35 (2010)
- Amin MB, "AJCC cancer staging manual" (2017), Springer
- Castellsague X, "HPV involvement in head and neck cancers : comprehensive assessment of biomarkers in 3680 patients", J Natl Cancer Inst, 108, pp.djv403~ (2016)
- Mehanna H, "Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer : systematic review and meta-analysis of trends by time and region", Head Neck, 35, pp.747~755 (2013)
- Chaturvedi AK, "Human papillomavirus and rising oropharyngeal cancer incidence in the United States", J Clin Oncol, 29, pp.4294~4301 (2011)
- Chaturvedi AK, "Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers", J Clin Oncol, 31, pp.4550~4559 (2013)
- Oh JK, "Prevalence of human papillomavirus-related diseases in the Republic of Korea : a cross-sectional study", Sex Transm Infect, 95, pp.292~299 (2019)
- Joo YH, "High-risk human papillomavirus and cervical lymph node metastasis in patients with oropharyngeal cancer", Head Neck, 34, pp.10~14 (2012)
- 김현수, "한국인 구강암 환자에서 인유두종 바이러스의 발현율 분석", Maxillofacial Plastic Reconstructive Surgery, 35(4), pp.227~235 (2013), 대한악안면성형재건외과학회
- 김해수, "Association between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma", Cancer Research and Treatment, 48(2), pp.527~536 (2016), 대한암학회
- Kim SH, "HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation", Int J Cancer, 120, pp.1418~1425 (2007)
- 박창수, "HPV Genotyping in Squamous Cell Carcinoma of Upper Aerodigestive Tract", Journal of Pathology and Translational Medicine, 44(5), pp.483~487 (2010), 대한병리학회
- Kwon MJ, "Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus-negative tonsillar squamous cell carcinoma and their prognostic significances", Hum Pathol, 45, pp.1327~1338 (2014)
- 이미지, "Human Papillomavirus Prevalence and Cell Cycle Related Protein Expression in Tonsillar Squamous Cell Carcinomas of Korean Patients with Clinicopathologic Analysis", Journal of Pathology and Translational Medicine, 47(2), pp.148~157 (2013), 대한병리학회[DOI]
- Lee SY, "Relevance of human papilloma virus(HPV)infection to carcinogenesis of oral tongue cancer", Int J Oral Maxillofac Surg, 39, pp.678~683 (2010)
- No JH, "Prevalence and prognostic value of human papillomavirus genotypes in tonsillar squamous cell carcinoma : a Korean multicenter study", Cancer, 121, pp.535~544 (2015)
- Park WS, "Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea : use of G1 cycle markers as new prognosticators", Head Neck, 34, pp.1408~1417 (2012)
- Shin KH, "Prevalence of microsatellite instability, inactivation of mismatch repair genes, p53 mutation, and human papillomavirus infection in Korean oral cancer patients", Int J Oncol, 21, pp.297~302 (2002)
- Vainshtein J, "Human papillomavirus-related oropharyngeal cancer : HPV and p16 status in the recurrent versus parent tumor", Head Neck, 37, pp.8~11 (2015)
- 송준선, "Expression of Human Papillomavirus-Related Proteins and Its Clinical Implication in Tonsillar Squamous Cell Carcinoma", Journal of Pathology and Translational Medicine, 46(2), pp.177~186 (2012), 대한병리학회[DOI]
- Oh TJ, "Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses", J Clin Microbiol, 42, pp.3272~3280 (2004)
- Kim MJ, "Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status", BMC Cancer, 14, pp.824~ (2014)
- Lee J, "Impact of p16 expression in oropharyngeal cancer in the postoperative setting : the necessity of re-evaluating traditional risk stratification", Jpn J Clin Oncol, 46, pp.911~918 (2016)
- Abogunrin S, "Prevalence of human papillomavirus in head and neck cancers in European populations : a meta-analysis", BMC Cancer, 14, pp.968~ (2014)
- Ndiaye C, "HPV DNA, E6", E7 mRNA, and p16INK4a detection in head and neck cancers : a systematic review and meta-analysis, 2014, pp.15, 1319~1331
- Shaikh MH, "HPV-associated head and neck cancers in the Asia Pacific : a critical literature review and meta-analysis", Cancer Epidemiol, 39, pp.923~938 (2015)
- Haeggblom L, "Time to change perspectives on HPV in oropharyngeal cancer : a systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years", Papillomavirus Res, 4, pp.1~11 (2017)
- Prigge ES, "Diagnostic accuracy of p16(INK4a)immunohistochemistry in oropharyngeal squamous cell carcinomas : a systematic review and meta-analysis", Int J Cancer, 140, pp.1186~1198 (2017)
- Qureishi A, "Current and future techniques for human papilloma virus(HPV)testing in oropharyngeal squamous cell carcinoma", Eur Arch Otorhinolaryngol, 274, pp.2675~2683 (2017)
- International Agency for Research on Cancer, "Biological agents", pp.275~276 (2012), IARC Press
- Bishop JA, "Human papillomavirus-related carcinomas of the sinonasal tract", Am J Surg Pathol, 37, pp.185~192 (2013)
- Laco J, "The presence of high-risk human papillomavirus(HPV)E6", E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis, 2015, pp.467, 405~415
- Larque AB, "High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas", Mod Pathol, 27, pp.343~351 (2014)
- Joo YH, "Characteristics and prognostic implications of high-risk HPV-associated hypopharyngeal cancers", PLoS One, 8, pp.e78718~ (2013)
- Lewis JS Jr, "Transcriptionally-active highrisk human papillomavirus is rare in oral cavity and laryngeal", hypopharyngeal squamous cell carcinomas : a tissue microarray study utilizing E6, Histopathology, pp.2012, 60[DOI]
- Syrjanen S, "HPV in head and neck carcinomas : different HPV profiles in oropharyngeal carcinomas : why", Acta Cytol, 63, pp.124~142 (2019)
- Benard VB, "Examining the association between socioeconomic status and potential human papillomavirus-associated cancers", Cancer, 113(10 Suppl), pp.2910~2918 (2008)
- Goodman MT, "Human papillomavirus genotype and oropharynx cancer survival in the United States of America", Eur J Cancer, 51, pp.2759~2767 (2015)
- Mazul AL, "Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma", Oral Oncol, 61, pp.98~103 (2016)
- Varier I, "Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes", Head Neck, 38, pp.1330~1337 (2016)